The presence of an operational classification of drug interactions (ORCA) class 3 or 4 drug-drug interactions (DDIs) did not increase the risk for colchicine-related gastrointestinal adverse events or ...
A drug used to treat gout could reduce the risk of a heart attack or stroke, according to a recent study. Researchers found ...
NEW YORK (Reuters Health) - The gout drug colchicine is safe for women to take during pregnancy, report researchers from Israel. In addition to the debilitating joint disorder gout, the ...
Please provide your email address to receive an email when new articles are posted on . Secondary prevention of CVD with colchicine is a major focus for the cardiology community, especially after ...
Gout is the most common form of inflammatory arthritis, with a worldwide prevalence of approximately 4%. The accumulation of ...
Also Read: COVID-19: Experts Suggest Avoid Going to Grocery Stores; Online Deliveries, Best Options? Can the anti-inflammatory drug colchicine prevent complications caused by COVID-19? In a previous ...
A press release from a Canadian research group raised hopes that treating people recently diagnosed with Covid-19 with colchicine, a drug commonly used to treat gout, could reduce the risk they will ...
An anti-inflammatory drug that has been around for over 2,000 years might help delay a very modern problem: hip and knee replacements. That's the suggestion of a new study finding that older adults ...
Due to a policy decision in 2010 by the U.S. Food and Drug Administration (FDA), the price of a prescription for the therapeutic gout drug colchicine increased nearly 16-fold from $11.25 in 2009 to ...
Men's Health on MSN
Researchers Found a Drug That Reduces Heart Attack Risk. It's as Low as $5.
There's one major similarity between gout and heart disease. Scientists are using that commonality to find affordable ways to ...
Due to a policy decision in 2010 by the U.S. Food and Drug Administration (FDA), the price of a prescription for the therapeutic gout drug colchicine increased nearly 16-fold from $11.25 in 2009 to ...
Taxpayer dollars spent on colchicine have spiked thanks to a regulatory quirk that enabled a company to exclusively market the centuries-old drug and allowed other manufacturers to follow suit. US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback